What is the official website of MSD Manufacturing Division (MMD) Haarlem ?

The official website of MSD Manufacturing Division (MMD) Haarlem is http://www.werkenbijmsd.nl.

What is MSD Manufacturing Division (MMD) Haarlem's cybersecurity risk score?

MSD Manufacturing Division (MMD) Haarlem has an AI-generated cybersecurity risk score of 770 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Manufacturing Division (MMD) Haarlem experienced?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Manufacturing Division (MMD) Haarlem been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Manufacturing Division (MMD) Haarlem have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem is not certified under SOC 2 Type 1.

Does MSD Manufacturing Division (MMD) Haarlem have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem does not hold a SOC 2 Type 2 certification.

Does MSD Manufacturing Division (MMD) Haarlem comply with GDPR ?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem is not listed as GDPR compliant.

Does MSD Manufacturing Division (MMD) Haarlem have PCI DSS certification ?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem does not currently maintain PCI DSS compliance.

Does MSD Manufacturing Division (MMD) Haarlem comply with HIPAA ?

According to Rankiteo, MSD Manufacturing Division (MMD) Haarlem is not compliant with HIPAA regulations.

Does MSD Manufacturing Division (MMD) Haarlem have ISO 27001 certification ?

According to Rankiteo,MSD Manufacturing Division (MMD) Haarlem is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Manufacturing Division (MMD) Haarlem operate in ?

MSD Manufacturing Division (MMD) Haarlem operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Manufacturing Division (MMD) Haarlem have ?

MSD Manufacturing Division (MMD) Haarlem employs approximately None employees people worldwide.

Does MSD Manufacturing Division (MMD) Haarlem own any subsidiaries ?

MSD Manufacturing Division (MMD) Haarlem presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Manufacturing Division (MMD) Haarlem have ?

MSD Manufacturing Division (MMD) Haarlem's official LinkedIn profile has approximately followers.

What is the NAICS classification code for MSD Manufacturing Division (MMD) Haarlem ?

MSD Manufacturing Division (MMD) Haarlem is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MSD Manufacturing Division (MMD) Haarlem have a Crunchbase profile ?

No, MSD Manufacturing Division (MMD) Haarlem does not have a profile on Crunchbase.

Does MSD Manufacturing Division (MMD) Haarlem have a LinkedIn profile ?

Yes, MSD Manufacturing Division (MMD) Haarlem maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-manufacturing-division-mmd-haarlem.

How many cybersecurity incidents has MSD Manufacturing Division (MMD) Haarlem experienced ?

As of June 14, 2026, Rankiteo reports that MSD Manufacturing Division (MMD) Haarlem has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Manufacturing Division (MMD) Haarlem have ?

MSD Manufacturing Division (MMD) Haarlem has an estimated 5,686 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Manufacturing Division (MMD) Haarlem faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MMDH

Boost Score +25 with badge (5 left)

770

/1000

Fair

795

/1000

Fair

MSD Manufacturing Division (MMD) Haarlem Vendor Cyber Rating & Cyber Score

werkenbijmsd.nl

Add Your Compliance Badge

MMD Haarlem produceert, verpakt en distribueert op hoge kwaliteit medicijnen. De tabletten in potjes en blisters, tot aan poeders worden via Haarlem naar meer dan 140 landen getransporteerd.

MMDH A.I CyberSecurity Scoring

Scoring History

MMDH

MSD Manufacturing Division (MMD) Haarlem CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Manufacturing D...

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MMDH Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MMDH

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Manufacturing Division (MMD) Haarlem in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Manufacturing Division (MMD) Haarlem in 2026.

Incident Types MMDH vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Manufacturing Division (MMD) Haarlem in 2026.

Incident History - MMDH (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Manufacturing Division (MMD) Haarlem Subsidiaries

MMDH

Pharmaceutical Manufacturing

Website: http://www.werkenbijmsd.nl

Company Size: None employees

MSDPharmaceutical Manufacturing

MSD Animal HealthPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD EspañaPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD DeutschlandPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD TürkiyePharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSDsalutePharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD NorgePharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

Curare MagazineHospitals and Health Care

MSD & diabetesHospitals and Health Care

MSD AcademyHospitals and Health Care

Loading…

MSD Manufacturing Division (MMD) Haarlem Similar Companies

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Loading…

NEWS

MSD Manufacturing Division (MMD) Haarlem CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-12175

SUMMARY

A vulnerability was detected in CodeAstro Student Attendance Management System 1.0. Impacted is an unknown function of the file /attendance-php/Admin/createStudents.php. Performing a manipulation of the argument admissionNumber results in sql injection. Remote exploitation of the attack is possible. The exploit is now public and may be used.

Published

Date2026-06-13

Updated

Date2026-06-13

RISK INFORMATION (Score: 4.7)

cvss2

Base Score: 5.8

Complexity: LOW

AV:N/AC:L/Au:M/C:P/I:P/A:P

cvss3

Base Score: 4.7

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.2

REFERENCES

CVE-2026-12174

SUMMARY

A security vulnerability has been detected in D-Link DCS-935L 1.10.01. This issue affects the function snprintf of the file /web/cgi-bin/greece/rhea of the component HTTP Handler. Such manipulation of the argument data leads to format string. The attack may be launched remotely. The exploit has been disclosed publicly and may be used.

Published

Date2026-06-13

Updated

Date2026-06-13

RISK INFORMATION (Score: 8.8)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 7.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-12183

SUMMARY

Nefteprodukttekhnika BUK TS-G Gas Station Automation System 2.9.1 through 2.10.2 on Linux contains an Improper Authentication vulnerability (CWE-287) in the system configuration module. The /php/ajax-login.php endpoint returns userid=1 (administrator) in response to any HTTP POST request that supplies arbitrary credentials (e.g., action=dologin&login=<any_value>&pwd=<any_value>), and subsequent privileged endpoints under /php/ajax-main.php and /modules/* do not validate a server-side session. A remote unauthenticated attacker can invoke any administrative action exposed by the configuration module, including reading and modifying user rules, fuel tank gauges, fuel dispensers, relays, cash registers, bank terminals, fuel cards, price and customer displays, cash collection, and pricing rules.

Published

Date2026-06-13

Updated

Date2026-06-13

RISK INFORMATION (Score: 9.8)

cvss3

Base Score: 9.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

3.9

REFERENCES

CVE-2026-6428

SUMMARY

SQL Injection in reports/catalogue_out.pl in Koha Community Koha through 22.11.37, 23.x, 24.x before 24.11.16, 25.05.x before 25.05.11, 25.11.x before 25.11.05, 26.05.x before 26.05.01, and 26.11.x before 26.11.00 allows an authenticated staff user with the Reports module flag to read arbitrary data from the Koha application database via the Filter URL parameter when the Criteria parameter matches /branchcode/. The vulnerable sink in sub calculate concatenates the unmodified Filter request parameter directly into a LIKE clause of the auxiliary $strsth2 statement and executes it via DBI without bound parameters: my $f = @$filters[0]; $f =~ s/\*/%/g; $strsth2 .= " AND $column LIKE '$f' "; This enables error-based SQL injection (e.g., via EXTRACTVALUE) and full read access to sensitive tables including borrowers (password hashes, 2FA secrets, PII), borrower_password_recovery, api_keys, and sessions. Proof of concept (error-based, single request): GET /cgi-bin/koha/reports/catalogue_out.pl?do_it=1&output=screen&Limit=10&Criteria=branchcode&Filter=x'+AND+EXTRACTVALUE(1,CONCAT(0x7e,VERSION(),0x7c,USER(),0x7c,DATABASE(),0x7e))--+- Cookie: CGISESSID=<LIBRARIAN_SESSION> The response body contains the DBI exception leaking the MariaDB version, database user, client IP, and database name, after which arbitrary data can be paged out using LIMIT n,1 / SUBSTRING(...). The vulnerable sink was introduced in commit 6bb77ae3e4 (2008-07-09); CVE-2015-4633 patched the same class in sibling files but did not generalise the fix to reports/catalogue_out.pl. Fixed in Koha 22.11.38, 24.11.16, 25.05.11, 25.11.05, 26.05.01, and 26.11.00 by replacing the raw concatenation with a parameterised placeholder.

Published

Date2026-06-13

Updated

Date2026-06-13

RISK INFORMATION (Score: 7.6)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:N/A:P

cvss3

Base Score: 7.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L

cvss4

Base Score: 5.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:Y/R:X/V:C/RE:X/U:Amber

Impact Score

4.7

Exploitability

2.8

REFERENCES

CVE-2026-5513

SUMMARY

The Online Scheduling and Appointment Booking System – Bookly plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'bookly-customer-full-name' cookie in versions up to, and including, 27.2 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. Exploitation requires 'Remember personal information in cookies' setting to be enabled (disabled by default).

Published

Date2026-06-13

Updated

Date2026-06-13

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:N

Impact Score

2.7

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…